Trospium

Trospium

SCHEMBL2447242

O=C(O[C@H]1C[C@H]2CC[C@@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM2CHRM3

The experimentally established mechanism targets of Trospium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRM3 known ✓ P20309 11/20 1.00
CHRM2 known ✓ P08172 10/20 1.00
CHRM1 P11229 4/20 1.00
KCNH2 Q12809 4/20 1.00
HRH1 P35367 3/20 1.00
CHRM4 P08173 1/20 0.97
CHRM5 P08912 1/20 0.97
OPRK1 P41145 1/20 0.62
LMNA P02545 2/20 0.60
CYP2D6 P10635 2/20 0.60
CYP2C19 P33261 1/20 0.60
SLC6A4 P31645 1/20 0.60
SLC22A1 O15245 1/20 0.58
RAB9A P51151 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trospium SCHEMBL119810 1.00 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL724191 1.00 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL31112961 0.99 CHRM3 (0.97) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL22609933 0.99 CHRM3 (0.97) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL29389006 0.99 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL111738 0.99 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL13836646 0.99 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL29629492 0.99 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL25785 0.99 CHRM3 (1.00) CHRM3CHRM2CHRM1KCNH2HRH1
Trospium SCHEMBL1707994 0.93 CHRM3 (0.89) CHRM3CHRM2CHRM1KCNH2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1880718-B1 Pharmaceutical preparation for oral administration with controlled drug release in the small intestine colon and process of prepartion thereof PFLEGER R CHEM FAB (DE) 2011-09-21 EP claimed
EP-4323367-A1 3H,4H-THIENO[2,3-D]PYRIMIDIN-4-ONE DERIVATIVES AS TRPA1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2024-02-21 EP disclosed
EP-4323364-A1 IMIDAZO[4,5-D]PYRIDAZINONYL DERIVATIVES AS TRPA1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2024-02-21 EP disclosed
EP-4323355-A1 URACIL DERIVATIVES AS TRPA1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2024-02-21 EP disclosed
EP-4228756-A1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2023-08-23 EP disclosed
EP-4228755-A1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2023-08-23 EP disclosed
EP-4171563-A1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2023-05-03 EP disclosed
EP-4171571-A1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2023-05-03 EP disclosed
WO-2022219012-A1 3H,4H,5H,6H,7H-PYRIMIDO[4,5-B][1,4]OXAZINE-4,6-DIONE DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-10-20 WO disclosed
WO-2022219013-A1 URACIL DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-10-20 WO disclosed
WO-2022219015-A1 IMIDAZO[4,5-d]PYRIDAZINONYL DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-10-20 WO disclosed
WO-2022219014-A1 3H,4H-THIENO[2,3-d]PYRIMIDIN-4-ONE DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-10-20 WO disclosed
EP-4045144-A1 THIENOPYRIMIDONES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-08-24 EP disclosed
EP-4045509-A1 THIENOPYRIMIDONES AS TRPA1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2022-08-24 EP disclosed
EP-4045053-A1 NOVEL TETRAZOLES Boehringer Ingelheim International GmbH (DE) 2022-08-24 EP disclosed
WO-2022079091-A1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-04-21 WO disclosed
WO-2022079092-A1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-04-21 WO disclosed